Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/25308
Type
ArticleCopyright
Restricted access
Embargo date
2030-01-01
Collections
- IOC - Artigos de Periódicos [12502]
Metadata
Show full item record
STATUS OF GLOBAL VIROLOGIC SURVEILLANCE FOR RUBELLA VIRUSES
Author
Abernathy, Emily S.
Hübschen, Judith M.
Muller, Claude P.
Jin, Li
Brown, David
Komase, Katsuhiro
Mori, Yoshio
Xu, Wenbo
Zhu, Zhen
Siqueira, Marilda Agudo Mendonça Teixeira de
Shulga, Sergey
Tikhonova, Nina
Pattamadilok, Sirima
Incomserb, Patcha
Smit, Sheilagh B.
Akoua-Koffi, Chantal
Bwogi, Josephine
Lim, Wilina W. L.
Woo, Gibson K. S.
Triki, Hinda
Jee, Youngmee
Mulders, Mick N.
Filippis, Ana Maria Bispo de
Ahmed, Hinda
Ramamurty, Nalini
Featherstone, David
Icenogle, Joseph P.
Hübschen, Judith M.
Muller, Claude P.
Jin, Li
Brown, David
Komase, Katsuhiro
Mori, Yoshio
Xu, Wenbo
Zhu, Zhen
Siqueira, Marilda Agudo Mendonça Teixeira de
Shulga, Sergey
Tikhonova, Nina
Pattamadilok, Sirima
Incomserb, Patcha
Smit, Sheilagh B.
Akoua-Koffi, Chantal
Bwogi, Josephine
Lim, Wilina W. L.
Woo, Gibson K. S.
Triki, Hinda
Jee, Youngmee
Mulders, Mick N.
Filippis, Ana Maria Bispo de
Ahmed, Hinda
Ramamurty, Nalini
Featherstone, David
Icenogle, Joseph P.
Affilliation
Centers for Disease Control and Prevention. National Center for Immunizations and Respiratory Diseases. Division of Viral Diseases. Atlanta, Georgia, USA.
Centre de Recherche Public-Santé. Laboratorie National de Santé. Institute of Immunology. Luxembourg.
Centre de Recherche Public-Santé. Laboratorie National de Santé. Institute of Immunology. Luxembourg.
Health Protection Agency. Centre for Infections. Virus Reference Department. London, United Kingdom.
Health Protection Agency. Centre for Infections. Virus Reference Department. London, United Kingdom.
National Institute of Infectious Diseases. Departmento of Virology III. Tokyo, Japan.
National Institute of Infectious Diseases. Departmento of Virology III. Tokyo, Japan.
Chinese Center for Disease Control and Prevention. National Institute for Viral Disease Control and Prevention. Beiing, China.
Chinese Center for Disease Control and Prevention. National Institute for Viral Disease Control and Prevention. Beiing, China.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Nacional de referência de Sarampo. Rio de Janeiro, RJ. Brasil.
Gabrichevsky G.N. Research Institute for Epidemiology and Microbiology. Moscow, Russia.
Gabrichevsky G.N. Research Institute for Epidemiology and Microbiology. Moscow, Russia.
National Institute of Health. Department of Medical Sciences. Nonthaburi, Thailand.
National Institute of Health. Department of Medical Sciences. Nonthaburi, Thailand.
National Institute for Communicable Diseases. Vaccine Preventable Virus Infections. Sandringham, South Africa.
Institut Pasteur de Coˆte d'Ivoire. Regional Reference Laboratory for Measles/Rubella. Abidjan, Côte d'Ivoire.
Ministry of Health. Uganda Virus Research Institute. Expanded Program for Immunization Laboratory. Entebbe, Uganda.
Centre for Health Protection. Department of Health. Public Health Laboratory Services. Kowloon, Hong Kong, China.
Centre for Health Protection. Department of Health. Public Health Laboratory Services. Kowloon, Hong Kong, China.
Institut Pateur de Tunis. Laboratory of Clinical Virology. Tunisia.
World Health Organization. Regional Office for the Western Pacific. Manila, Philippines.
WHO Regional Office for Europe. Copenhagen, Denmark.
WHO Pan American Health Organization. Washington, D.C., USA.
WHO Regional Office for the Eastern Mediterranean. Cairo, Egypt.
WHO Regional Office for South-East Asia., New Delhi, India.
WHO. Department of Immunization, Vaccines, and Biologicals, Family. Community Health Cluster. Geneva, Switzerland.
Centers for Disease Control and Prevention. National Center for Immunizations and Respiratory Diseases. Division of Viral Diseases. Atlanta, Georgia, USA.
Centre de Recherche Public-Santé. Laboratorie National de Santé. Institute of Immunology. Luxembourg.
Centre de Recherche Public-Santé. Laboratorie National de Santé. Institute of Immunology. Luxembourg.
Health Protection Agency. Centre for Infections. Virus Reference Department. London, United Kingdom.
Health Protection Agency. Centre for Infections. Virus Reference Department. London, United Kingdom.
National Institute of Infectious Diseases. Departmento of Virology III. Tokyo, Japan.
National Institute of Infectious Diseases. Departmento of Virology III. Tokyo, Japan.
Chinese Center for Disease Control and Prevention. National Institute for Viral Disease Control and Prevention. Beiing, China.
Chinese Center for Disease Control and Prevention. National Institute for Viral Disease Control and Prevention. Beiing, China.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Nacional de referência de Sarampo. Rio de Janeiro, RJ. Brasil.
Gabrichevsky G.N. Research Institute for Epidemiology and Microbiology. Moscow, Russia.
Gabrichevsky G.N. Research Institute for Epidemiology and Microbiology. Moscow, Russia.
National Institute of Health. Department of Medical Sciences. Nonthaburi, Thailand.
National Institute of Health. Department of Medical Sciences. Nonthaburi, Thailand.
National Institute for Communicable Diseases. Vaccine Preventable Virus Infections. Sandringham, South Africa.
Institut Pasteur de Coˆte d'Ivoire. Regional Reference Laboratory for Measles/Rubella. Abidjan, Côte d'Ivoire.
Ministry of Health. Uganda Virus Research Institute. Expanded Program for Immunization Laboratory. Entebbe, Uganda.
Centre for Health Protection. Department of Health. Public Health Laboratory Services. Kowloon, Hong Kong, China.
Centre for Health Protection. Department of Health. Public Health Laboratory Services. Kowloon, Hong Kong, China.
Institut Pateur de Tunis. Laboratory of Clinical Virology. Tunisia.
World Health Organization. Regional Office for the Western Pacific. Manila, Philippines.
WHO Regional Office for Europe. Copenhagen, Denmark.
WHO Pan American Health Organization. Washington, D.C., USA.
WHO Regional Office for the Eastern Mediterranean. Cairo, Egypt.
WHO Regional Office for South-East Asia., New Delhi, India.
WHO. Department of Immunization, Vaccines, and Biologicals, Family. Community Health Cluster. Geneva, Switzerland.
Centers for Disease Control and Prevention. National Center for Immunizations and Respiratory Diseases. Division of Viral Diseases. Atlanta, Georgia, USA.
Abstract
The suspected measles case definition captures rubella cases. Therefore, measles surveillance will be improved in the course of the control and eventual elimination of rubella transmission. One aspect of rubella control, virologic surveillance, is reviewed here. A systematic nomenclature for rubella viruses (RVs) based on 13 genotypes has been established and is updated when warranted by increases in information about RVs. From 2005 through 2010, the genotypes of RVs most frequently reported were 1E, 1G, and 2B, and genotypes 1a, 1B, 1C, 1h, 1j, and 2C were less frequently reported. Virologic surveillance can support rubella control and elimination. Synopses of rubella virologic surveillance in various countries, regions, and globally are given, including characterization of viruses from imported cases in a country that has eliminated rubella and studies of endemic viruses circulating in countries without rubella control objectives. Current challenges are discussed.
Share